Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sanofi (SNYNF) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Sanofi (SNYNF) over the last 17 years, with Q4 2025 value amounting to -$7.7 billion.

  • Sanofi's Profit After Tax fell 151368.8% to -$7.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $11.7 billion, marking a year-over-year increase of 9107.33%. This contributed to the annual value of $8.9 billion for FY2025, which is 4591.43% up from last year.
  • As of Q4 2025, Sanofi's Profit After Tax stood at -$7.7 billion, which was down 151368.8% from $10.1 billion recorded in Q3 2025.
  • In the past 5 years, Sanofi's Profit After Tax ranged from a high of $10.1 billion in Q3 2025 and a low of -$7.7 billion during Q4 2025
  • Over the past 5 years, Sanofi's median Profit After Tax value was $1.9 billion (recorded in 2021), while the average stood at $2.0 billion.
  • Examining YoY changes over the last 5 years, Sanofi's Profit After Tax showed a top increase of 50772.26% in 2025 and a maximum decrease of 151368.8% in 2025.
  • Over the past 5 years, Sanofi's Profit After Tax (Quarter) stood at $1.3 billion in 2021, then soared by 147.62% to $3.2 billion in 2022, then crashed by 118.58% to -$600.4 million in 2023, then surged by 190.95% to $546.1 million in 2024, then plummeted by 1513.69% to -$7.7 billion in 2025.
  • Its Profit After Tax stands at -$7.7 billion for Q4 2025, versus $10.1 billion for Q3 2025 and $7.3 billion for Q2 2025.